UBS Group’s Aethlon Medical AEMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.96K | Buy |
+179
| New | +$2.04K | ﹤0.01% | 9391 |
|
|
2025
Q3 | – | Sell |
-33
| Closed | -$1.96K | – | 10291 |
|
|
2025
Q2 | $1.96K | Sell |
33
-134
| -80% | -$18K | ﹤0.01% | 9541 |
|
|
2025
Q1 | $23.9K | Sell |
167
-457
| -73% | -$106K | ﹤0.01% | 8107 |
|
|
2024
Q4 | $215K | Buy |
624
+78
| +14% | +$13.2K | ﹤0.01% | 6406 |
|
|
2024
Q3 | $102K | Buy |
546
+542
| +13,550% | +$86.1K | ﹤0.01% | 6353 |
|
|
2024
Q2 | $863 | Buy |
+4
| New | +$1.58K | ﹤0.01% | 8756 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 8715 |
|
|
2023
Q4 | – | Sell |
-1
| Closed | -$711 | – | 8886 |
|
|
2023
Q3 | $869 | Hold |
1
| – | – | ﹤0.01% | 8239 |
|
|
2023
Q2 | $1.14K | Sell |
1
-2
| -67% | -$2.93K | ﹤0.01% | 8003 |
|
|
2023
Q1 | $4.76K | Buy |
+3
| New | +$5.65K | ﹤0.01% | 8151 |
|
|
2022
Q4 | – | Sell |
-3
| Closed | -$5.47K | – | 10332 |
|
|
2022
Q3 | $7K | Buy |
+3
| New | +$13K | ﹤0.01% | 8838 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 9802 |
|
|
2022
Q1 | – | Sell |
-1
| Closed | -$5.97K | – | 9828 |
|
|
2021
Q4 | $8K | Buy |
+1
| New | +$11.4K | ﹤0.01% | 9010 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8923 |
|
|
2021
Q2 | – | Sell |
-3
| Closed | -$34.5K | – | 8305 |
|
|
2021
Q1 | $21K | Buy |
3
+2
| +200% | +$19.2K | ﹤0.01% | 7328 |
|
|
2020
Q4 | $8K | Buy |
+1
| New | +$6.68K | ﹤0.01% | 7608 |
|
|
2020
Q3 | – | Sell |
-1
| Closed | -$6.77K | – | 7623 |
|
|
2020
Q2 | $10K | Hold |
1
| – | – | ﹤0.01% | 6995 |
|
|
2020
Q1 | $7K | Buy |
+1
| New | +$8.46K | ﹤0.01% | 7122 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7915 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7715 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7825 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7517 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7613 |
|
|
2018
Q2 | – | Hold |
0
| – | -$3K | – | 7945 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7404 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7688 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 7381 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6895 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 7156 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6908 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 7500 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6448 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 7409 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 8124 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 7399 |
|
Other funds holding AEMD
IC
SC
XT
TRCT
CIAM
UBS Group's AEMD Position: Q1 2026 in Review
UBS Group opened a new position in Aethlon Medical (AEMD) in Q1 2026: 179 shares worth $1.96K. The stake represents ﹤0.01% of the portfolio and ranks #9391 among its holdings. This is a return to the name: UBS Group previously reported a position in AEMD as recently as Q2 2025.
UBS Group first reported a position in AEMD in Q1 2020 and has held it in 15 quarters since. The position peaked at $215K in Q4 2024. 11 funds tracked by Wall St. Rank hold AEMD as of Q1 2026.
- UBS Group held 179 shares of Aethlon Medical worth $1.96K as of Q1 2026.
- Aethlon Medical was a new UBS Group position in Q1 2026.
- Aethlon Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9391 holding.
- UBS Group first reported a position in Aethlon Medical in Q1 2020 and has held it in 15 quarters since.
- UBS Group's Aethlon Medical position peaked at $215K in Q4 2024.
- 11 funds tracked by Wall St. Rank held Aethlon Medical as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.